Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapyYun Zhou, Min Zheng, Chang-Long Chen et al.|OncoImmunology|2018Cited by 27
Anlotinib plus pemetrexed as a further treatment for patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study.Jueming Chen, Yanna Zhang, Xingyu Jiang et al.|Journal of Clinical Oncology|2021Cited by 2
Anlotinib (AL3818) plus pemetrexed in patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A single-arm, open-label, phase II study.Yanna Zhang, He Huang, Jueming Chen et al.|Journal of Clinical Oncology|2020Cited by 1
SLUG is Enhanced by Chemotherapeutics and Functions to Promote Invasion and Metastasis by Directly Targeting MMP3 in Cervical CancerSenwei Jiang, Min Zheng, Lan Zhang et al.|Research Square|2020Cited by 0
265P: Association between digestive system diseases and lung cancer risk: A comprehensive evaluation based on UK biobankYanling Feng, Wenhua Liang, Xiangyi Zheng et al.|Journal of Thoracic Oncology|2025Cited by 0